Related Experiment Videos
The FDA report on intraocular lenses.
Australian Journal of Ophthalmology
|February 1, 1984
Summary
Over one million intraocular lenses (IOLs) have been implanted since 1978, with 85% achieving good vision. Patient age and complications can impact visual acuity outcomes.
Area of Science:
- Ophthalmology
- Medical Device Regulation
Background:
- Clinical studies of intraocular lenses (IOLs) as investigational devices are regulated by the U.S. Food and Drug Administration (FDA).
- Data collection on IOLs began in February 1978, with over one million implanted by August 1982.
Purpose of the Study:
- To review clinical data on intraocular lens (IOL) implantation and outcomes.
- To identify factors affecting visual acuity after IOL surgery.
Main Methods:
- Analysis of data from over one million implanted intraocular lenses (IOLs).
- Review of 45,000 cases to assess visual acuity at one year post-surgery.
Main Results:
- 85% of patients achieved 20/40 or better visual acuity one year after surgery.
- Factors such as increasing patient age, surgical issues, and complications negatively impacted visual acuity.
- The trend in the USA favors posterior and anterior chamber IOL implantation.
Conclusions:
- Intraocular lens (IOL) implantation has a high success rate in improving visual acuity.
- Monitoring patient age, surgical technique, and complications is crucial for optimal outcomes.
- Posterior and anterior chamber IOLs are the current standard in the USA.